Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -3,129.17% vs -118.18% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -75.00% vs -14.29% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of 180 Life Sciences Corp. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 20.83% vs -41.46% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 66.52% vs -10.92% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -3,129.17% vs -118.18% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 56.25% vs 95.65% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -75.00% vs -14.29% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -62.96% vs 800.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






